Specifications
Species Reactivity
Mouse; Rat; Human
Immunogen
Recombinant full length protein (Human).
Applications
Application Notes
WB: 1/1000 - 1/2000; IHC-Fr: 1/40 - 1/100; IHC-P: 1/40 - 1/100;
Target
Alternative Names
ABI1; abl-interactor 1; spectrin SH3 domain binding protein 1 , SSH3BP1; abl interactor 1; ABI 1; E3B1; Abelson interactor 1; nap1 binding protein; abl-binding protein 4; interactor protein AblBP4; Abl-interactor protein 1 long; eps8 SH3 domain-binding pr
Product Background
Antigen Description
May act in negative regulation of cell growth and transformation by interacting with nonreceptor tyrosine kinases ABL1 and/or ABL2. May play a role in regulation of EGF-induced Erk pathway activation. Involved in cytoskeletal reorganization and EGFR signaling. Together with EPS8 participates in transduction of signals from Ras to Rac. In vitro, a trimeric complex of ABI1, EPS8 and SOS1 exhibits Rac specific guanine nucleotide exchange factor (GEF) activity and ABI1 seems to act as an adapter in the complex. Regulates ABL1/c-Abl-mediated phosphorylation of ENAH. Recruits WASF1 to lamellipodia and there seems to regulate WASF1 protein level.
Pathway
E-cadherin signaling in the nascent adherens junction, organism-specific biosystem; EGFR1 Signaling Pathway, organism-specific biosystem; ErbB1 downstream signaling, organism-specific biosystem; RAC1 signaling pathway, organism-specific biosystem; Regulation of RAC1 activity, organism-specific biosystem; Stabilization and expansion of the E-cadherin adherens junction, organism-specific biosystem; T Cell Receptor Signaling Pathway, organism-specific biosystem;
Citations
Publication ()
Have you cited DCABH-351 in a publication?
Let us know and earn a reward for your research.